Review




Structured Review

Partec partec pa ii flow cytometer
Partec Pa Ii Flow Cytometer, supplied by Partec, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/partec pa ii flow cytometer/product/Partec
Average 86 stars, based on 1 article reviews
partec pa ii flow cytometer - by Bioz Stars, 2026-05
86/100 stars

Images



Similar Products

86
Partec partec pa ii flow cytometer
Partec Pa Ii Flow Cytometer, supplied by Partec, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/partec pa ii flow cytometer/product/Partec
Average 86 stars, based on 1 article reviews
partec pa ii flow cytometer - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

86
Partec ca ii flow 123 cytometer
Ca Ii Flow 123 Cytometer, supplied by Partec, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ca ii flow 123 cytometer/product/Partec
Average 86 stars, based on 1 article reviews
ca ii flow 123 cytometer - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

86
Merck & Co amnis imagestream x mark ii flow cytometer
Amnis Imagestream X Mark Ii Flow Cytometer, supplied by Merck & Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/amnis imagestream x mark ii flow cytometer/product/Merck & Co
Average 86 stars, based on 1 article reviews
amnis imagestream x mark ii flow cytometer - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

86
Tree Star Inc facs canto ii flow cytometer
Facs Canto Ii Flow Cytometer, supplied by Tree Star Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/facs canto ii flow cytometer/product/Tree Star Inc
Average 86 stars, based on 1 article reviews
facs canto ii flow cytometer - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

86
Merck & Co imagestream x mark ii imaging flow cytometer
Experimental strategy for evaluating autologous platelet effects on anti-tumor immunity of NK cells. ( A ) K562 cells were treated with platelets freshly isolated from healthy donors at a ratio of 1:500 for 3 h. Simultaneously, NK cells were purified from the same blood donors, then co-cultured with the K562 cells, which had been pre-treated with or without platelets, at a ratio of 4:1. After 16-hour incubation, we evaluated the anti-tumor responses of NK cells and the viability changes of K562 cells using flow cytometry. ( B ) Gating strategy for K562 cells. We gated on K562 cells and applied FSC-A versus FSC-H parameters to exclude doublets before analyzing CD61 signals. ( C ) CD61 + platelets on CFSE-labeled K562 cells. Representative plots (upper panel) show the percentage of CD61 + fluorescence on CFSE + K562 cells. Histograms (lower panel) display the MFI of CD61 on CFSE + K562 cells. ( D ) Summary of CD61 positivity of CFSE + K562 cells with or without platelet pre-treatment ( n = 10). ( E ) Fluorescent photographs of CD61 (PerCP-Cy5.5, red signal, excitation/emission: 488 nm/695 nm)- and CFSE (green signal, excitation/emission: 488 nm/518–521 nm) - labeled cells with or without platelets pre-treatment were taken by <t>ImageStream</t> ® X Mark II imaging flow cytometer. MFI, mean fluorescence intensity; **, p < 0.01
Imagestream X Mark Ii Imaging Flow Cytometer, supplied by Merck & Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/imagestream x mark ii imaging flow cytometer/product/Merck & Co
Average 86 stars, based on 1 article reviews
imagestream x mark ii imaging flow cytometer - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

86
Merck & Co imagestream x mark ii imaging 189 flow cytometer
Experimental strategy for evaluating autologous platelet effects on anti-tumor immunity of NK cells. ( A ) K562 cells were treated with platelets freshly isolated from healthy donors at a ratio of 1:500 for 3 h. Simultaneously, NK cells were purified from the same blood donors, then co-cultured with the K562 cells, which had been pre-treated with or without platelets, at a ratio of 4:1. After 16-hour incubation, we evaluated the anti-tumor responses of NK cells and the viability changes of K562 cells using flow cytometry. ( B ) Gating strategy for K562 cells. We gated on K562 cells and applied FSC-A versus FSC-H parameters to exclude doublets before analyzing CD61 signals. ( C ) CD61 + platelets on CFSE-labeled K562 cells. Representative plots (upper panel) show the percentage of CD61 + fluorescence on CFSE + K562 cells. Histograms (lower panel) display the MFI of CD61 on CFSE + K562 cells. ( D ) Summary of CD61 positivity of CFSE + K562 cells with or without platelet pre-treatment ( n = 10). ( E ) Fluorescent photographs of CD61 (PerCP-Cy5.5, red signal, excitation/emission: 488 nm/695 nm)- and CFSE (green signal, excitation/emission: 488 nm/518–521 nm) - labeled cells with or without platelets pre-treatment were taken by <t>ImageStream</t> ® X Mark II imaging flow cytometer. MFI, mean fluorescence intensity; **, p < 0.01
Imagestream X Mark Ii Imaging 189 Flow Cytometer, supplied by Merck & Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/imagestream x mark ii imaging 189 flow cytometer/product/Merck & Co
Average 86 stars, based on 1 article reviews
imagestream x mark ii imaging 189 flow cytometer - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

99
Danaher Inc cytoflex ii flow cytometer
Experimental strategy for evaluating autologous platelet effects on anti-tumor immunity of NK cells. ( A ) K562 cells were treated with platelets freshly isolated from healthy donors at a ratio of 1:500 for 3 h. Simultaneously, NK cells were purified from the same blood donors, then co-cultured with the K562 cells, which had been pre-treated with or without platelets, at a ratio of 4:1. After 16-hour incubation, we evaluated the anti-tumor responses of NK cells and the viability changes of K562 cells using flow cytometry. ( B ) Gating strategy for K562 cells. We gated on K562 cells and applied FSC-A versus FSC-H parameters to exclude doublets before analyzing CD61 signals. ( C ) CD61 + platelets on CFSE-labeled K562 cells. Representative plots (upper panel) show the percentage of CD61 + fluorescence on CFSE + K562 cells. Histograms (lower panel) display the MFI of CD61 on CFSE + K562 cells. ( D ) Summary of CD61 positivity of CFSE + K562 cells with or without platelet pre-treatment ( n = 10). ( E ) Fluorescent photographs of CD61 (PerCP-Cy5.5, red signal, excitation/emission: 488 nm/695 nm)- and CFSE (green signal, excitation/emission: 488 nm/518–521 nm) - labeled cells with or without platelets pre-treatment were taken by <t>ImageStream</t> ® X Mark II imaging flow cytometer. MFI, mean fluorescence intensity; **, p < 0.01
Cytoflex Ii Flow Cytometer, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cytoflex ii flow cytometer/product/Danaher Inc
Average 99 stars, based on 1 article reviews
cytoflex ii flow cytometer - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

86
Merck & Co imagestreamx mark ii flow cytometer
Experimental strategy for evaluating autologous platelet effects on anti-tumor immunity of NK cells. ( A ) K562 cells were treated with platelets freshly isolated from healthy donors at a ratio of 1:500 for 3 h. Simultaneously, NK cells were purified from the same blood donors, then co-cultured with the K562 cells, which had been pre-treated with or without platelets, at a ratio of 4:1. After 16-hour incubation, we evaluated the anti-tumor responses of NK cells and the viability changes of K562 cells using flow cytometry. ( B ) Gating strategy for K562 cells. We gated on K562 cells and applied FSC-A versus FSC-H parameters to exclude doublets before analyzing CD61 signals. ( C ) CD61 + platelets on CFSE-labeled K562 cells. Representative plots (upper panel) show the percentage of CD61 + fluorescence on CFSE + K562 cells. Histograms (lower panel) display the MFI of CD61 on CFSE + K562 cells. ( D ) Summary of CD61 positivity of CFSE + K562 cells with or without platelet pre-treatment ( n = 10). ( E ) Fluorescent photographs of CD61 (PerCP-Cy5.5, red signal, excitation/emission: 488 nm/695 nm)- and CFSE (green signal, excitation/emission: 488 nm/518–521 nm) - labeled cells with or without platelets pre-treatment were taken by <t>ImageStream</t> ® X Mark II imaging flow cytometer. MFI, mean fluorescence intensity; **, p < 0.01
Imagestreamx Mark Ii Flow Cytometer, supplied by Merck & Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/imagestreamx mark ii flow cytometer/product/Merck & Co
Average 86 stars, based on 1 article reviews
imagestreamx mark ii flow cytometer - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

86
Merck & Co canto ii flow cytometer
Experimental strategy for evaluating autologous platelet effects on anti-tumor immunity of NK cells. ( A ) K562 cells were treated with platelets freshly isolated from healthy donors at a ratio of 1:500 for 3 h. Simultaneously, NK cells were purified from the same blood donors, then co-cultured with the K562 cells, which had been pre-treated with or without platelets, at a ratio of 4:1. After 16-hour incubation, we evaluated the anti-tumor responses of NK cells and the viability changes of K562 cells using flow cytometry. ( B ) Gating strategy for K562 cells. We gated on K562 cells and applied FSC-A versus FSC-H parameters to exclude doublets before analyzing CD61 signals. ( C ) CD61 + platelets on CFSE-labeled K562 cells. Representative plots (upper panel) show the percentage of CD61 + fluorescence on CFSE + K562 cells. Histograms (lower panel) display the MFI of CD61 on CFSE + K562 cells. ( D ) Summary of CD61 positivity of CFSE + K562 cells with or without platelet pre-treatment ( n = 10). ( E ) Fluorescent photographs of CD61 (PerCP-Cy5.5, red signal, excitation/emission: 488 nm/695 nm)- and CFSE (green signal, excitation/emission: 488 nm/518–521 nm) - labeled cells with or without platelets pre-treatment were taken by <t>ImageStream</t> ® X Mark II imaging flow cytometer. MFI, mean fluorescence intensity; **, p < 0.01
Canto Ii Flow Cytometer, supplied by Merck & Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/canto ii flow cytometer/product/Merck & Co
Average 86 stars, based on 1 article reviews
canto ii flow cytometer - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

86
Partec flow cytometer partec ii
Experimental strategy for evaluating autologous platelet effects on anti-tumor immunity of NK cells. ( A ) K562 cells were treated with platelets freshly isolated from healthy donors at a ratio of 1:500 for 3 h. Simultaneously, NK cells were purified from the same blood donors, then co-cultured with the K562 cells, which had been pre-treated with or without platelets, at a ratio of 4:1. After 16-hour incubation, we evaluated the anti-tumor responses of NK cells and the viability changes of K562 cells using flow cytometry. ( B ) Gating strategy for K562 cells. We gated on K562 cells and applied FSC-A versus FSC-H parameters to exclude doublets before analyzing CD61 signals. ( C ) CD61 + platelets on CFSE-labeled K562 cells. Representative plots (upper panel) show the percentage of CD61 + fluorescence on CFSE + K562 cells. Histograms (lower panel) display the MFI of CD61 on CFSE + K562 cells. ( D ) Summary of CD61 positivity of CFSE + K562 cells with or without platelet pre-treatment ( n = 10). ( E ) Fluorescent photographs of CD61 (PerCP-Cy5.5, red signal, excitation/emission: 488 nm/695 nm)- and CFSE (green signal, excitation/emission: 488 nm/518–521 nm) - labeled cells with or without platelets pre-treatment were taken by <t>ImageStream</t> ® X Mark II imaging flow cytometer. MFI, mean fluorescence intensity; **, p < 0.01
Flow Cytometer Partec Ii, supplied by Partec, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/flow cytometer partec ii/product/Partec
Average 86 stars, based on 1 article reviews
flow cytometer partec ii - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

Image Search Results


Experimental strategy for evaluating autologous platelet effects on anti-tumor immunity of NK cells. ( A ) K562 cells were treated with platelets freshly isolated from healthy donors at a ratio of 1:500 for 3 h. Simultaneously, NK cells were purified from the same blood donors, then co-cultured with the K562 cells, which had been pre-treated with or without platelets, at a ratio of 4:1. After 16-hour incubation, we evaluated the anti-tumor responses of NK cells and the viability changes of K562 cells using flow cytometry. ( B ) Gating strategy for K562 cells. We gated on K562 cells and applied FSC-A versus FSC-H parameters to exclude doublets before analyzing CD61 signals. ( C ) CD61 + platelets on CFSE-labeled K562 cells. Representative plots (upper panel) show the percentage of CD61 + fluorescence on CFSE + K562 cells. Histograms (lower panel) display the MFI of CD61 on CFSE + K562 cells. ( D ) Summary of CD61 positivity of CFSE + K562 cells with or without platelet pre-treatment ( n = 10). ( E ) Fluorescent photographs of CD61 (PerCP-Cy5.5, red signal, excitation/emission: 488 nm/695 nm)- and CFSE (green signal, excitation/emission: 488 nm/518–521 nm) - labeled cells with or without platelets pre-treatment were taken by ImageStream ® X Mark II imaging flow cytometer. MFI, mean fluorescence intensity; **, p < 0.01

Journal: Cancer Cell International

Article Title: Interferon-α enhances NK cell function to counteract autologous platelet-mediated tumor immune evasion

doi: 10.1186/s12935-025-04118-w

Figure Lengend Snippet: Experimental strategy for evaluating autologous platelet effects on anti-tumor immunity of NK cells. ( A ) K562 cells were treated with platelets freshly isolated from healthy donors at a ratio of 1:500 for 3 h. Simultaneously, NK cells were purified from the same blood donors, then co-cultured with the K562 cells, which had been pre-treated with or without platelets, at a ratio of 4:1. After 16-hour incubation, we evaluated the anti-tumor responses of NK cells and the viability changes of K562 cells using flow cytometry. ( B ) Gating strategy for K562 cells. We gated on K562 cells and applied FSC-A versus FSC-H parameters to exclude doublets before analyzing CD61 signals. ( C ) CD61 + platelets on CFSE-labeled K562 cells. Representative plots (upper panel) show the percentage of CD61 + fluorescence on CFSE + K562 cells. Histograms (lower panel) display the MFI of CD61 on CFSE + K562 cells. ( D ) Summary of CD61 positivity of CFSE + K562 cells with or without platelet pre-treatment ( n = 10). ( E ) Fluorescent photographs of CD61 (PerCP-Cy5.5, red signal, excitation/emission: 488 nm/695 nm)- and CFSE (green signal, excitation/emission: 488 nm/518–521 nm) - labeled cells with or without platelets pre-treatment were taken by ImageStream ® X Mark II imaging flow cytometer. MFI, mean fluorescence intensity; **, p < 0.01

Article Snippet: Subsequently, fluorescent images of each cell were directly acquired using the ImageStream ® X Mark II imaging flow cytometer (Merck) and Confocal microscopy (Leica).

Techniques: Isolation, Purification, Cell Culture, Incubation, Flow Cytometry, Labeling, Fluorescence, Imaging